Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Capital Expenditures (2016 - 2020)

Historic Capital Expenditures for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to $7000.0.

  • Glucotrack's Capital Expenditures rose 146950.67% to $7000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $53000.0, marking a year-over-year increase of 13043.48%. This contributed to the annual value of $1000.0 for FY2022, which is 8000.0% down from last year.
  • Glucotrack's Capital Expenditures amounted to $7000.0 in Q4 2020, which was up 146950.67% from $31000.0 recorded in Q3 2020.
  • In the past 5 years, Glucotrack's Capital Expenditures registered a high of $31000.0 during Q3 2020, and its lowest value of $446.0 during Q4 2019.
  • For the 5-year period, Glucotrack's Capital Expenditures averaged around $10359.2, with its median value being $6378.0 (2019).
  • As far as peak fluctuations go, Glucotrack's Capital Expenditures tumbled by 9383.43% in 2017, and later soared by 146950.67% in 2020.
  • Glucotrack's Capital Expenditures (Quarter) stood at $28872.0 in 2016, then plummeted by 49.37% to $14618.0 in 2017, then plummeted by 87.23% to $1866.0 in 2018, then crashed by 76.1% to $446.0 in 2019, then skyrocketed by 1469.51% to $7000.0 in 2020.
  • Its Capital Expenditures was $7000.0 in Q4 2020, compared to $31000.0 in Q3 2020 and $15000.0 in Q1 2020.